JANA ZBINDEN: Open Payments
NPI 1801099163 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 48 payments from 13 companies in 2025. Trend: 2023 $561 · 2024 $1,424 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $315 |
| Novartis Pharmaceuticals Corporation | 11 | $308 |
| Vifor Pharma, Inc. | 7 | $168 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| Calliditas Therapeutics US Inc. | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| Travere Therapeutics, Inc. | 2 | $51 |
| Medtronic, Inc. | 1 | $48 |
| OPKO Pharmaceuticals, LLC | 3 | $46 |
Products named: Fabhalta, XPHOZAH 30 MG, Veltassa, ULTOMIRIS, TARPEYO, JYNARQUE, JARDIANCE, IBSRELA.
Industry payments across TN — which companies pay providers there.
